This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...